Obesity & Overweight
164
58
70
34
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 164 trials
100.0%
+13.5% vs benchmark
4%
7 trials in Phase 3/4
3%
1 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 34 completed trials
Clinical Trials (164)
Effect of a High-Protein Diet With Meal Replacements on Weight Loss
Digitally Enhanced Cognitive-Behavioral Therapy
PLAY2CONTROL Study
The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened Beverages
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight
Concurrent Exercise Effects in Post-Bariatric Patients
Effects of HIIT Following PTR Programme
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Diet and WB-EMS Effects in Obesity
The OAT-RCT Study: The Obesity Anti-Coagulation Thromboprophylaxis Randomised Controlled Trial.
Real-world Exploration of Digital iNnovation in the Management of Excess Weight
COMPASS 65+ - Community-based Physical Activity Snacks for Healthy Aging in Overweight and Obese Aged Adults
Effects of Whole-Body Vibration With Foot Core Exercises: A Randomized Controlled Trial
Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.
Augmenting Primary Care-Based Obesity Management With the Nutu™ Digital Health Platform
Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood
Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1